“Movantik (naloxegol) 12.5 mg and 25 mg Tablets for the "Treatment of Opioid-Induced Constipation (OIC) in Adult Patients with Non-Cancer Pain”

Thursday March 16, Georges Low Country Table at 2095 S. Milledge Av. 6:30pm.

RSVP:  John.mathis@astrazeneca.com    Please share with other providers

The title for the presentation is as follows:
“Movantik (naloxegol) 12.5 mg and 25 mg Tablets for the Treatment of Opioid-Induced Constipation (OIC) in Adult Patients with Non-Cancer Pain”

Brief Bio:  JT is a Pharm D by training. He received his BS in Pharmacy at the University of S. Carolina and his doctorate from Shenandoah University in Virginia. He now works as a Medical Science Liaison with AstraZeneca focusing on scientific exchange, research, publications, etc. He covers the following 4 states: NC, SC ,Tn. and Georgia focusing on Gastroenterology and Neuroscience.

From Julie Rosdeutscher Crowe:  

Can you help get this word out? If we get enough ppl to attend we can have brief chapter mtg.This should be really good- the speaker comes highly recommended. Please RSVP at email:   John.mathis@astrazeneca.com